상품명칭 |
뉴로메딘 C |
별명 |
; 봄베신 데카펩티드; 개 가스트린-방출 펩티드 10; 가스린은 펩티드를 방출한다 (18-27); 가스트린은 펩티드 10을 방출하고; Gly-asn-his-trp-ala-val-gly-his-leu-met-NH2; 그르프 (18-27); Grp-10; (2S)-2-[(2-아미노아세틸)아미노]-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[2-[[(1S)-2-[[(1S)-1-[[(1S)-1-1--카르바모일-3-메틸설파닐-프로필]카르바모일]-3-메틸-부틸]아미노]-1-(3H-이미다졸-4-일메틸)-2-옥소-에틸]아미노]-2-옥소-에틸]카르바모일]-2-메틸-프로필]아미노]-1-메틸-2-옥소-에틸]아미노]-1-(1H-인돌-3-일메틸)-2-옥소-에틸]아미노]-1-(3H-이미다졸-4-일메틸)-2-옥소-에틸]부탄디아미드 |
영문 이름 |
Neuromedin C; Bombesin decapeptide; Canine gastrin-releasing peptide 10; Gastrin releasing peptide (18-27); Gastrin releasing peptide 10; Gly-asn-his-trp-ala-val-gly-his-leu-met-NH2; Grp (18-27); Grp-10; (2S)-2-[(2-aminoacetyl)amino]-N-[(1S)-2-[[(1S)-2-[[(1S)-2-[[(1S)-1-[[2-[[(1S)-2-[[(1S)-1-[[(1S)-1-carbamoyl-3-methylsulfanyl-propyl]carbamoyl]-3-methyl-butyl]amino]-1-(3H-imidazol-4-ylmethyl)-2-oxo-ethyl]amino]-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]amino]-1-methyl-2-oxo-ethyl]amino]-1-(1H-indol-3-ylmethyl)-2-oxo-ethyl]amino]-1-(3H-imidazol-4-ylmethyl)-2-oxo-ethyl]butanediamide |
분자식 |
C50H73N17O11S |
분자량 |
1120.2869 |
InChI |
InChI=1/C50H73N17O11S/c1-25(2)13-34(46(74)63-33(43(53)71)11-12-79-6)64-47(75)36(15-29-20-54-23-58-29)62-41(70)22-57-50(78)42(26(3)4)67-44(72)27(5)60-45(73)35(14-28-19-56-32-10-8-7-9-31(28)32)65-48(76)37(16-30-21-55-24-59-30)66-49(77)38(17-39(52)68)61-40(69)18-51/h7-10,19-21,23-27,33-38,42,56H,11-18,22,51H2,1-6H3,(H2,52,68)(H2,53,71)(H,54,58)(H,55,59)(H,57,78)(H,60,73)(H,61,69)(H,62,70)(H,63,74)(H,64,75)(H,65,76)(H,66,77)(H,67,72)/t27-,33-,34-,35-,36-,37-,38-,42-/m0/s1 |
cas번호 |
81608-30-2 |
분자 구조 |
|
밀도 |
1.338g/cm3 |
비등점 |
1730.4°C at 760 mmHg |
굴절 지수 |
1.61 |
인화점 |
1000.3°C |
증기압 |
0mmHg at 25°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|